Rel-O-2050

• Description:

  Rel-O-2050 (Compound O-2050) is a neutral cannabinoid CB1 receptor antagonist. rel-O-2050 also decreases food intake in mice[1].

• UNSPSC:

  12352005

• Target:

  Cannabinoid Receptor

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein; Neuronal Signaling

• Applications:

  Metabolism-protein/nucleotide metabolism

• Field of Research:

  Metabolic Disease

• Assay Protocol:

  https://www.medchemexpress.com/rel-o-2050.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CS (=O) (NCCCC#CCC1=CC (O) =C ([C@@]2 ([H]) [C@] (CC=C (C) C2) ([H]) C (C) (C) O3) C3=C1) =O

• Molecular Formula:

  C23H31NO4S

• Molecular Weight:

  417.56

• References & Citations:

  [1]Wiley JL, et al. Structural and pharmacological analysis of O-2050, a putative neutral cannabinoid CB (1) receptor antagonist. Eur J Pharmacol. 2011 Jan 25;651 (1-3) :96-105.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• Isoform:

  CB1

• CAS Number:

  851320-29-1